Mason Benjamin, Pharmd Email & Phone Number

Cambridge, Massachusetts, United States

• Developed and maintained key relationships with external patient advocacy stakeholders in Rare Diseases, Rare Blood Disorders, Oncology, and Rheumatology• Collaborated with cross-functional teams to advance strategic projects for issues that mattered most to patients and aligned with internal objectives• Proactively identified opportunities to further the company’s relationship with communities of interest and demonstrated we are a partner who listens and acts to solve issues affecting patients• Supported clinical development programs through external trial awareness efforts and by providing solutions to existing internal and external trial enrollment barriers• Understood patient experiences and communicated insights to internal stakeholders to ensure that the patient voice was present and incorporated throughout the drug development process• Ensured external presentation materials and communications were compliant with company rules and regulatory authority guidelines, and handled compliance review submissions• Additional cross-functional project experiences with Sanofi’s Global Public Affairs & Patient Advocacy, Value & Access, and Managed Access Program teams

Greater Boston

Beijing, China

Chicago, Il

• Explained diseases, pharmacology, treatment guidelines, and patient journeys to nonclinical team members at an advertising agency in plain language empowering them to create effective advertisements

Chicago, Il

• Performed competitive intelligence to evaluate potential product acquisitions and inform the clinical development programs within Paragon’s portfolio of seven biopharmaceutical companies• Wrote the regulatory strategy for the lifecycle management of a neuroscience acquisition, ecopipam, the background on unmet need section for its fast-track designation request submission, and the protocol for a Phase II Open-Label Extension Study (NCT04114539)

Windhoek, Namibia

• Served as the principle investigator in the data-collection phase of a project aimed at increasing the healthcare delivery capacity of pharmacists in Namibia through education and best practice research by identifying and sharing current accomplishments and opportunities for future improvement• Designed qualitative interview questions and carried out in-person quantitative and qualitative data collection in Namibia to assess current practices and enable the design of future interventions• Evaluated the University of Namibia School of Pharmacy’s rotation program to enable college leadership to modify their curriculum as necessary based on outcomes from the first two graduating classes

Ann Arbor, Michigan, United States

• Helped solve the customer acquisition problem faced by a genomic technology start-up company resulting in 100-fold user growth over 7 weeks following adoption of suggested business model changes• Identified a previously unexplored revenue stream which immediately reduced the company’s venture funding needs and was projected to be a primary revenue driver moving forward• Collaborated on the delivery of an investor pitch with a $5,000,000 ask to career venture capitalists for the start-up company’s Series-A financing round and handled technical and business model Q&A

Titusville, New Jersey

• Improved patient Instructions For Use (IFU) documentation to better reflect product safety information in patient-friendly language to reduce the risk of accidental exposure to opioids• Designed a clinical study outline to support the needs of the local team in India and communicated project goals to ensure the global and national teams were aligned on the work’s future direction

Boulder, Co

Doctor Of Pharmacy (Pharmd)

Mba Coursework, Venture Capital Finance, Healthcare Innovation, Commercialization Of Biomedicine, Entrepreneurship

Certificate Of Neuroscience, Neuroscience

Bachelor Of Arts (B.A.), Psychology